# RLAY (Relay Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Relay Therapeutics, Inc. reported $10.35M in revenue and a net loss of $293.6M for the trailing twelve months ended September 30, 2026 (up 53.4% year over year), with a -3094.6% operating margin.

- Canonical: https://convexityos.com/fundamentals/RLAY
- Markdown: https://convexityos.com/fundamentals/RLAY.md
- SEC CIK: 0001812364
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:17 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001812364&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $10.35M | +53.4% YoY |
| Operating Income | TTM | -$320.3M | -3094.6% margin |
| Net Income | TTM | -$293.6M | -2837.0% net margin |
| Diluted EPS | TTM | -$1.61 | Split-adjusted |
| Free Cash Flow | TTM | -$235.9M | -2278.9% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $124.2M | Total debt: $27.03M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $15.36M | $10.01M | $25.55M | $1.38M | $3.03M | $82.65M | -- |
| Research & Development | $261.4M | $319.1M | $330.0M | $246.4M | $172.7M | $99.86M | $70.31M |
| Total Operating Expenses | $318.1M | $382.5M | $398.5M | $300.7M | $367.7M | $138.4M | $84.05M |
| **Operating Income** | -$302.7M | -$372.5M | -$373.0M | -$299.3M | -$364.7M | -$55.80M | -$84.05M |
| **EBITDA** | -$299.2M | -$367.0M | -$367.7M | -$295.1M | -$360.8M | -$52.25M | -$81.20M |
| Interest Income | $27.04M | $34.75M | $31.05M | $8.79M | $830K | $3.40M | $8.80M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$276.5M | -$337.7M | -$342.0M | -$290.5M | -$363.9M | -$52.41M | -$75.31M |
| Basic EPS | -$1.61 | -$2.36 | -$2.79 | -$2.59 | -$3.82 | -$5.40 | -$21.82 |
| **Diluted EPS** | -$1.61 | -$2.36 | -$2.79 | -$2.59 | -$3.82 | -$5.40 | -$21.82 |
| Basic Shares Outstanding | 171.6M | 142.9M | 122.6M | 112.2M | 95.1M | 42.6M | 3.5M |
| Diluted Shares Outstanding | -- | -- | -- | 112.2M | 95.1M | 42.6M | 3.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $350K | $3.00M | $7.00M | $0 | $677K | $7.68M | $0 |
| Research & Development | $77.14M | $76.48M | $70.56M | $55.41M | $68.26M | $63.90M | $73.81M | $68.08M |
| Total Operating Expenses | $90.25M | $91.17M | $81.59M | $67.63M | $80.39M | $77.52M | $92.55M | $84.98M |
| **Operating Income** | -$90.25M | -$90.82M | -$78.59M | -$60.63M | -$80.39M | -$76.85M | -$84.87M | -$84.98M |
| **EBITDA** | -$89.97M | -$90.46M | -$78.09M | -$60.03M | -$79.64M | -$75.84M | -$83.66M | -$83.64M |
| Interest Income | $8.50M | $7.12M | $5.35M | $5.71M | $6.41M | $7.11M | $7.81M | $8.97M |
| **Net Income** | -$81.75M | -$83.71M | -$73.29M | -$54.89M | -$74.15M | -$70.38M | -$77.06M | -$76.00M |
| Basic EPS | -$0.37 | -$0.41 | -$0.41 | -- | -$0.43 | -$0.41 | -$0.46 | -- |
| **Diluted EPS** | -$0.37 | -$0.41 | -$0.41 | -- | -$0.43 | -$0.41 | -$0.46 | -- |
| Basic Shares Outstanding | 219.2M | 202.8M | 179.8M | -- | 172.4M | 171.3M | 169.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $84.02M | $124.3M | $143.7M | $151.8M | $280.1M | $447.6M | $41.95M |
| **Cash & Short-Term Investments** | $84.02M | $124.3M | $143.7M | $151.8M | $280.1M | $447.6M | $41.95M |
| Accounts Receivable, Net | -- | -- | -- | $306K | $403K | $75.00M | -- |
| Other Current Assets | $5.97M | $10.53M | $3.31M | $3.26M | $1.76M | -- | -- |
| **Total Current Assets** | $578.3M | $809.2M | $770.1M | $1.02B | $976.2M | $770.1M | $360.5M |
| Property, Plant & Equipment, Net | $1.73M | $5.91M | $10.90M | $11.63M | $6.54M | $6.25M | $8.09M |
| Intangible Assets | -- | -- | $2.30M | $2.30M | $2.30M | -- | -- |
| **Total Non-Current Assets** | $43.05M | $62.09M | $73.88M | $80.27M | $32.20M | $29.73M | $32.53M |
| **Total Assets** | $621.3M | $871.3M | $844.0M | $1.10B | $1.01B | $799.8M | $393.1M |
| Accounts Payable | $7.71M | $14.10M | $9.21M | $10.58M | $8.28M | $6.35M | $6.99M |
| Deferred Revenue (Current) | -- | $7.68M | -- | -- | $248K | -- | -- |
| Other Current Liabilities | $463K | $1.99M | $1.20M | $26.15M | $396K | -- | -- |
| **Total Current Liabilities** | $25.58M | $50.73M | $30.27M | $63.71M | $24.32M | $13.63M | $11.99M |
| Other Non-Current Liabilities | -- | -- | -- | -- | $15.00M | -- | -- |
| **Total Non-Current Liabilities** | $28.69M | $42.77M | $61.71M | $85.84M | $86.31M | $22.90M | $23.74M |
| **Total Liabilities** | $54.27M | $93.50M | $91.98M | $149.6M | $110.6M | $36.54M | $35.73M |
| **Total Debt (incl. Leases)** | $32.46M | $48.50M | $53.47M | $57.74M | $22.90M | $24.42M | $24.83M |
| Common Stock | $168K | $168K | $127K | $121K | $109K | $90K | -- |
| Retained Earnings | -$2.01B | -$1.74B | -$1.40B | -$1.06B | -$768.1M | -$404.2M | -$189.5M |
| Accumulated Other Comp. Income | $733K | -$991K | -$196K | -$10.42M | -$1.09M | $64K | $325K |
| **Total Stockholders' Equity** | $567.1M | $777.8M | $752.0M | $950.2M | $897.8M | $763.3M | -$180.4M |
| Total Equity | $567.1M | $777.8M | $752.0M | $950.2M | $897.8M | $763.3M | -$180.4M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $124.2M | $121.2M | $204.6M | $84.02M | $91.56M | $113.9M | $93.54M | $124.3M |
| **Cash & Short-Term Investments** | $124.2M | $121.2M | $204.6M | $84.02M | $91.56M | $113.9M | $93.54M | $124.3M |
| Other Current Assets | $7.53M | $8.41M | $4.56M | $5.97M | $3.74M | $7.58M | $7.35M | $10.53M |
| **Total Current Assets** | $864.9M | $928.1M | $658.5M | $578.3M | $624.0M | $680.4M | $739.7M | $809.2M |
| Property, Plant & Equipment, Net | $582K | $862K | $1.22M | $1.73M | $2.36M | $3.46M | $5.15M | $5.91M |
| Intangible Assets | $4.75M | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $36.84M | $39.38M | $41.15M | $43.05M | $45.99M | $48.45M | $59.70M | $62.09M |
| **Total Assets** | $901.7M | $967.5M | $699.6M | $621.3M | $670.0M | $728.8M | $799.4M | $871.3M |
| Accounts Payable | $9.19M | $11.46M | $4.10M | $7.71M | $2.75M | $5.18M | $8.45M | $14.10M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | $7.68M |
| Other Current Liabilities | $1.42M | $1.25M | $847K | $463K | $1.08M | $609K | $1.68M | $1.99M |
| **Total Current Liabilities** | $59.15M | $50.80M | $29.75M | $25.58M | $32.60M | $32.52M | $37.05M | $50.73M |
| **Total Non-Current Liabilities** | $23.54M | $26.64M | $27.68M | $28.69M | $29.69M | $30.66M | $41.23M | $42.77M |
| **Total Liabilities** | $82.70M | $77.45M | $57.43M | $54.27M | $62.29M | $63.18M | $78.28M | $93.50M |
| **Total Debt (incl. Leases)** | $27.03M | $30.66M | $31.57M | $32.46M | $33.33M | $34.18M | $47.16M | $48.50M |
| Common Stock | $212K | $211K | $182K | $168K | $168K | $168K | $168K | $168K |
| Retained Earnings | -$2.25B | -$2.17B | -$2.09B | -$2.01B | -$1.96B | -$1.89B | -$1.82B | -$1.74B |
| Accumulated Other Comp. Income | -$5.36M | -$1.55M | -$172K | $733K | $493K | -$163K | $38K | -$991K |
| **Total Stockholders' Equity** | $819.0M | $890.0M | $642.2M | $567.1M | $607.7M | $665.7M | $721.1M | $777.8M |
| Total Equity | $819.0M | $890.0M | $642.2M | $567.1M | $607.7M | $665.7M | $721.1M | $777.8M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$276.5M | -$337.7M | -$342.0M | -$290.5M | -$363.9M | -$52.41M | -$75.31M |
| Depreciation & Amortization | $3.56M | $5.46M | $5.27M | $4.13M | $3.92M | $3.55M | $2.85M |
| Stock-Based Compensation | $62.42M | $94.14M | $86.03M | $56.14M | $48.45M | $31.96M | $4.46M |
| Change in Receivables | -- | -- | $306K | $97K | $74.68M | -$75.00M | -- |
| Change in Payables | -- | -- | -$2.39M | $1.99M | $930K | -$410K | $3.00M |
| **Operating Cash Flow** | -$235.5M | -$249.1M | -$300.3M | -$229.5M | -$74.41M | -$102.5M | -$66.13M |
| Capital Expenditure | -$410K | -$2.02M | -$4.13M | -$9.06M | -$3.47M | -$1.93M | -$8.00M |
| **Free Cash Flow** | -$235.9M | -$251.1M | -$304.4M | -$238.6M | -$77.88M | -$104.4M | -$74.14M |
| Acquisitions, Net | -- | -- | -- | -- | -$25.30M | -- | -- |
| Purchases of Investments | -$123.0M | -$650.6M | -$385.5M | -$535.4M | -$980.7M | -$266.5M | -$553.5M |
| **Investing Cash Flow** | $192.8M | -$41.08M | $257.6M | -$188.7M | -$479.5M | $81.67M | -$319.0M |
| Common Stock Issued | -- | -- | -- | -- | $4.74M | $1.22M | $613K |
| **Financing Cash Flow** | $1.60M | $270.2M | $34.75M | $289.9M | $388.1M | $426.5M | $5.61M |
| **Net Change in Cash** | -$41.05M | -$20.04M | -$7.93M | -$128.3M | -$165.8M | $405.7M | -$379.6M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$81.75M | -$83.71M | -$73.29M | -$54.89M | -$74.15M | -$70.38M | -$77.06M | -$76.00M |
| Depreciation & Amortization | $280K | $360K | $504K | $599K | $748K | $1.00M | $1.21M | $1.33M |
| Stock-Based Compensation | $10.12M | $9.18M | $10.54M | $13.07M | $15.53M | $14.50M | $19.32M | $17.64M |
| **Operating Cash Flow** | -$63.93M | -$54.11M | -$51.11M | -$44.87M | -$62.12M | -$55.26M | -$73.21M | -$57.87M |
| Capital Expenditure | -- | -- | -- | -$1.0K | $1.0K | -$26K | -$384K | $0 |
| **Free Cash Flow** | -- | -- | -- | -$44.87M | -$62.12M | -$55.29M | -$73.59M | -$57.87M |
| Purchases of Investments | -$121.5M | -$471.3M | -$50.90M | -$34.00M | -$58.08M | -$8.93M | -$21.97M | -$75.08M |
| **Investing Cash Flow** | $62.37M | -$353.0M | $32.90M | $35.46M | $39.73M | $75.15M | $42.47M | $29.00M |
| **Financing Cash Flow** | $4.42M | $323.7M | $138.8M | -- | -- | -- | -- | $800K |
| **Net Change in Cash** | $2.86M | -$83.40M | $120.6M | -$8.47M | -$22.38M | $20.54M | -$30.75M | -$28.07M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -1971.6% | -3722.1% | -1460.1% | -21670.9% | -12040.2% | -67.5% | -- |
| **Net Profit Margin** | -1800.6% | -3374.7% | -1338.7% | -21036.1% | -12012.9% | -63.4% | -- |
| Return on Equity (ROE) | -48.8% | -43.4% | -45.5% | -30.6% | -40.5% | -6.9% | -- |
| Return on Assets (ROA) | -44.5% | -38.8% | -40.5% | -26.4% | -36.1% | -6.6% | -19.2% |
| Current Ratio | 22.61x | 15.95x | 25.44x | 16.00x | 40.14x | 56.49x | 30.08x |
| Quick Ratio | 3.28x | 2.45x | 4.75x | 2.39x | 11.53x | 38.34x | 3.50x |
| Debt to Equity | 0.06x | 0.06x | 0.07x | 0.06x | 0.03x | 0.03x | -- |
| **Revenue Growth (YoY)** | +53.4% | -60.8% | +1749.8% | -54.4% | -96.3% | -- | -- |
| 5Y Revenue / Share Growth | -95.4% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -3094.6% | -2999.4% | -2776.6% | -1971.5% | -3914.4% | -4105.6% | -4778.9% | -3722.1% |
| **Net Profit Margin** | -2837.0% | -2763.6% | -2554.1% | -1800.5% | -3561.4% | -3728.4% | -4341.5% | -3374.7% |
| Return on Equity (ROE) | -35.9% | -32.1% | -42.5% | -48.8% | -49.0% | -46.8% | -46.2% | -43.4% |
| Return on Assets (ROA) | -32.6% | -29.6% | -39.0% | -44.5% | -44.4% | -42.7% | -41.7% | -38.8% |
| Current Ratio | 14.62x | 18.27x | 22.13x | 22.61x | 19.14x | 20.92x | 19.96x | 15.95x |
| Quick Ratio | 2.10x | 2.39x | 6.88x | 3.28x | 2.81x | 3.50x | 2.52x | 2.45x |
| Debt to Equity | 0.03x | 0.03x | 0.05x | 0.06x | 0.05x | 0.05x | 0.07x | 0.06x |
| **Revenue Growth (YoY)** | -- | -48.3% | -60.9% | -- | -- | -- | -23.3% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
